Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Virtual Reality for Pain Management During Dupilumab Injection [NA]

View source ↗

Summary

A clinical trial is evaluating virtual reality as an adjunct analgesic during dupilumab injections for atopic dermatitis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUPIXENT (DUPILUMAB)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Atopic Dermatitis, Pain | NA | Status: RECRUITING